Repare Therapeutics

Repare is developing new, precision oncology drugs for patients that target specific vulnerabilities of tumor cells.

Launch date

2016

Employees

Market cap

Enterprise valuation

(€51m) (Public information from Sep 2024)

Montreal Quebec (HQ)

http://www.reparerx.com/

https://twitter.com/reparerx https://www.linkedin.com/company/repare-therapeutics

View job openings

Authorizing premium user...